bullish
Major Milestone Ahead for Mesoblast as Japanese Partner Moves Closer to Market with JR-031
283 Views08 Sep 2015 10:00
Mesoblast's Japanese partner, JCR Pharmaceuticals, has announced that its acute Graft versus Host Disease, or aGvHD, product, JR-031, was...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 42-minute read)
Discussions
(Paid Plans Only)
Morningstar, Inc.
Leading Independent Investment Research
Price Chart(Sign Up to Access)
x